Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T22:51:06.308Z.
Calculation as of: 2026-10-06T22:51:06.308Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5ff4a69d5e0bd829addfa263bba904bf87580f902e4d2830b11cef9910c58a28
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2019-03-28.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$122.66M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$127.29M
EV/EBITDA Ratio
N/A
TTM Avg
3271.29x
3Y Avg
2827.81x
5Y Avg
2827.81x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $124.70M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | N/A | N/A | N/A | N/A |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $122.43M | N/A | N/A | N/A | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | N/A | 3271.29x | 2827.81x | 2827.81x |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.98M | N/A | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | N/A | N/A | N/A | N/A |
| Seer, Inc. (SEER)vs › | $120.41M | N/A | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $119.84M | N/A | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2019-03-28 | 3.51x |
| 2019-03-27 | 3.31x |
| 2019-03-26 | 3.12x |
| 2019-03-25 | 2.91x |
| 2019-03-22 | 3.40x |
| 2019-03-21 | 3.40x |
| 2019-03-20 | 3.35x |
| 2019-03-19 | 3.31x |
| 2019-03-18 | 3.28x |
| 2019-03-15 | 3.46x |
| 2019-03-14 | 3.58x |
| 2019-03-13 | 3.58x |
| 2019-03-12 | 3.66x |
| 2019-03-11 | 3.49x |
| 2019-03-08 | 3.70x |
| 2019-03-07 | 3.26x |
| 2019-03-06 | 3.45x |
| 2019-03-05 | 3.49x |
| 2019-03-04 | 3.59x |
| 2019-03-01 | 3.62x |
| 2019-02-28 | 3.53x |
| 2019-02-27 | 3.51x |
| 2019-02-26 | 3.52x |
| 2019-02-25 | 3.68x |
| 2019-02-22 | 3.75x |
| 2019-02-21 | 3.27x |
| 2019-02-20 | 3.64x |
| 2019-02-19 | 3.68x |
| 2019-02-15 | 3.98x |
| 2019-02-14 | 4.00x |
| 2019-02-13 | 4.04x |
| 2019-02-12 | 3.81x |
| 2019-02-11 | 4.09x |
| 2019-02-08 | 3.37x |
| 2019-02-07 | 3.31x |
| 2019-02-06 | 3.33x |
| 2019-02-05 | 3.51x |
| 2019-02-04 | 3.42x |
| 2019-02-01 | 3.34x |
| 2019-01-31 | 3.14x |
| 2019-01-30 | 3.14x |
| 2019-01-29 | 3.18x |
| 2019-01-28 | 3.18x |
| 2019-01-25 | 2.91x |
| 2019-01-24 | 2.80x |
| 2019-01-23 | 2.46x |
| 2019-01-22 | 2.55x |
| 2019-01-18 | 2.80x |
| 2019-01-17 | 3.10x |
| 2019-01-16 | 3.05x |
| 2019-01-15 | 2.07x |
| 2019-01-14 | 2.31x |
| 2019-01-11 | 2.17x |
| 2019-01-10 | 2.30x |
| 2019-01-09 | 2.51x |
| 2019-01-08 | 2.26x |
| 2019-01-07 | 2.25x |
| 2019-01-04 | 2.17x |
| 2019-01-03 | 2.28x |
| 2019-01-02 | 2.02x |
| 2018-12-31 | 2.06x |
| 2018-12-28 | 2.32x |
| 2018-12-27 | 2.24x |
| 2018-12-26 | 2.00x |
| 2018-12-24 | 2.49x |
| 2018-12-21 | 2.29x |
| 2018-12-20 | 2.23x |
| 2018-12-19 | 2.82x |
| 2018-12-18 | 3.02x |
| 2018-12-17 | 3.01x |
| 2018-12-14 | 3.09x |
| 2018-12-13 | 3.59x |
| 2018-12-12 | 3.81x |
| 2018-12-11 | 4.14x |
| 2018-12-10 | 4.82x |
| 2018-12-07 | 4.26x |
| 2018-12-06 | 4.26x |
| 2018-12-04 | 4.57x |
| 2018-12-03 | 4.61x |
| 2018-11-30 | 4.62x |
| 2018-11-29 | 4.61x |
| 2018-11-28 | 4.61x |
| 2018-11-27 | 4.61x |
| 2018-11-26 | 4.61x |
| 2018-11-23 | 4.61x |
| 2018-11-21 | 4.61x |
| 2018-11-20 | 4.61x |
| 2018-11-19 | 4.61x |
| 2018-11-16 | 4.61x |
| 2018-11-15 | 4.61x |
| 2018-11-14 | 4.46x |
| 2018-11-13 | 4.52x |
| 2018-11-12 | 4.50x |
| 2018-11-09 | 4.54x |
| 2018-11-08 | 4.55x |
| 2018-11-07 | 5.06x |
| 2018-11-06 | 4.55x |
| 2018-11-05 | 4.49x |
| 2018-11-02 | 4.55x |
| 2018-11-01 | 4.82x |
| 2018-10-31 | 5.06x |
| 2018-10-30 | 4.53x |
| 2018-10-29 | 5.12x |
| 2018-10-26 | 4.96x |
| 2018-10-25 | 4.92x |
| 2018-10-24 | 5.00x |
| 2018-10-23 | 4.60x |
| 2018-10-22 | 5.08x |
| 2018-10-19 | 5.08x |
| 2018-10-18 | 5.03x |
| 2018-10-17 | 4.97x |
| 2018-10-16 | 4.97x |
| 2018-10-15 | 5.00x |
| 2018-10-12 | 4.75x |
| 2018-10-11 | 4.78x |
| 2018-10-10 | 4.32x |
| 2018-10-09 | 4.56x |
| 2018-10-08 | 5.23x |
| 2018-10-05 | 5.23x |
| 2018-10-04 | 5.21x |
| 2018-10-03 | 5.21x |
| 2018-10-02 | 5.06x |
| 2018-10-01 | 4.33x |
| 2018-09-28 | 5.32x |
| 2018-09-27 | 4.92x |
| 2018-09-26 | 5.00x |
| 2018-09-25 | 4.97x |
| 2018-09-24 | 4.64x |
| 2018-09-21 | 4.77x |
| 2018-09-20 | 4.78x |
| 2018-09-19 | 4.67x |
| 2018-09-18 | 4.67x |
| 2018-09-17 | 4.67x |
| 2018-09-14 | 4.67x |
| 2018-09-13 | 4.55x |
| 2018-09-12 | 4.44x |
| 2018-09-11 | 4.54x |
| 2018-09-10 | 4.29x |
| 2018-09-07 | 5.15x |
| 2018-09-06 | 5.40x |
| 2018-09-05 | 4.75x |
| 2018-09-04 | 4.92x |
| 2018-08-31 | 4.92x |
| 2018-08-30 | 4.25x |
| 2018-08-29 | 4.24x |
| 2018-08-28 | 4.06x |
| 2018-08-27 | 4.20x |
| 2018-08-24 | 4.25x |
| 2018-08-23 | 4.06x |
| 2018-08-22 | 4.15x |
| 2018-08-21 | 4.52x |
